meningeal tuberculosis
meningeal tuberculosis
Explore linked clinical trials. Standard reference: MONDO:00060428 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| B-PaLMZ for TB Meningitis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, disease arising from reactivation of latent virus, gram-positive bacterial infections, latent tuberculosis infection, meningeal tuberculosis, meningitis, mycobacterial infectious disease, nervous system disorder, tuberculosis | Recruiting | Phase 2 | 2026-09-30 | NCT07227779 | |
| Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-positive bacterial infections, meningeal tuberculosis, meningitis, mycobacterial infectious disease, nervous system disorder, tuberculosis | Recruiting | Phase 3 | 2026-06-24 | NCT04145258 | |
| Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-positive bacterial infections, meningeal tuberculosis, meningitis, mycobacterial infectious disease, nervous system disorder, tuberculosis | Recruiting | Phase 2 | 2026-06-02 | NCT05383742 | |
| Adjunctive Doxycycline for Central Nervous System Tuberculosis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, brain disorder, central nervous system disorder, central nervous system infectious disorder, encephalitis, gram-positive bacterial infections, meningeal tuberculosis, meningitis, meningoencephalitis, mycobacterial infectious disease, nervous system disorder, tuberculosis, viral infection of central nervous system | Recruiting | Phase 2 | 2026-06-01 | NCT06446245 | |
| Phase 2a Trial of Alpibectir Plus Ethionamide for Tuberculosis Meningitis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-positive bacterial infections, meningeal tuberculosis, meningitis, mycobacterial infectious disease, nervous system disorder, tuberculosis | Not yet recruiting | Phase 2 | 2026-03-03 | NCT07350174 | |
| Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-positive bacterial infections, meningeal tuberculosis, meningitis, mycobacterial infectious disease, nervous system disorder, tuberculosis | Recruiting | Phase 2 | 2025-12-15 | NCT05590455 | |
| Phase II Clinical Study of Contezolid for the Treatment of Tuberculous Meningitis | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-positive bacterial infections, meningeal tuberculosis, meningitis, mycobacterial infectious disease, nervous system disorder, tuberculosis | Enrolling by invitation | Phase 1 / Phase 2 | 2025-02-06 | NCT06811025 | |
| Intensified Short Course Regimen for TBM in Adults | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Infections, Neuroinflammatory Diseases, Tuberculosis, Central Nervous System, Tuberculosis, Extrapulmonary, bacterial infectious disease, bacterial meningitis, central nervous system disorder, central nervous system infectious disorder, gram-positive bacterial infections, meningeal tuberculosis, meningitis, mycobacterial infectious disease, nervous system disorder, tuberculosis | Not yet recruiting | Phase 3 | 2023-12-21 | NCT05917340 |